Elise Mekkaoui is a French entrepreneur and the co-founder of Matricis.ai, a health technology company that uses artificial intelligence to improve the diagnosis of endometriosis. Through her work, she is helping doctors identify a disease that affects millions of women worldwide but often takes years to diagnose. Her journey combines personal experience, technical curiosity, business knowledge, and a strong commitment to women’s health.
As co-founder and a senior leader at Matricis.ai, Elise has helped transform a research project into a growing health-tech company that collaborates with hospitals, researchers, and radiologists. Her goal is simple but ambitious: to make medical diagnosis faster, more accurate, and more accessible for women everywhere.
Early Life and Education
Elise Mekkaoui grew up in the Paris region of France and developed a strong interest in mathematics from an early age. During her school years, she was known for her curiosity and determination. She pursued a rigorous academic path that combined science, mathematics, business, and law, giving her a multidisciplinary perspective that would later prove valuable in entrepreneurship.
Before entering the startup world, Elise considered a career in public service. She even prepared for a path that could have led her into government administration. However, her interests gradually shifted toward innovation and problem-solving. She became increasingly fascinated by artificial intelligence and its potential to solve complex real-world challenges.
Her passion for understanding complicated systems and finding practical solutions became a defining characteristic of her career.
A Personal Motivation to Solve a Major Health Problem
The idea behind Matricis.ai was not born in a boardroom. It came from a deeply personal experience.
Elise experienced firsthand the challenges associated with endometriosis, a disease that affects millions of women but is frequently diagnosed late. Many patients spend years seeking answers before receiving a proper diagnosis. In some cases, women are misdiagnosed several times before the disease is identified correctly. This long diagnostic journey can have significant consequences for quality of life, fertility, and overall health.
Rather than accepting the problem, Elise began exploring whether artificial intelligence could help improve diagnosis. She recognized that MRI interpretation for endometriosis is complex and requires specialized expertise that is not always available. This challenge created an opportunity for technology to support medical professionals.
Her personal connection to the issue gave her a clear sense of purpose. She wanted to build a tool that could reduce diagnostic delays and help women receive treatment sooner.
The Founding of Matricis.ai
In 2022, Elise discussed her idea with her close friend Raphaelle Taub, a physicist with startup experience. Raphaelle immediately saw the potential of the concept and joined the project. Together, they began building what would eventually become Matricis.ai.
The founders understood that success would require strong medical expertise alongside technical innovation. They reached out to leading radiologists and medical specialists, including experts from major French healthcare institutions. One important early collaboration involved Professor Elisabeth Dion, a recognized radiology expert who helped strengthen the scientific foundation of the project.
The young company quickly attracted attention from Inria, France’s National Institute for Research in Digital Science and Technology. Support from Inria provided valuable resources, mentorship, and research capabilities that helped accelerate development. Matricis.ai later became an official spin-off linked to Inria and AP-HP, one of Europe’s largest hospital systems.
The company was formally established in late 2023 in Paris. Elise became one of its key leaders, while Raphaelle Taub took on the role of Chief Executive Officer.
Building Technology for Better Diagnosis
Matricis.ai focuses on developing AI-powered tools that assist radiologists in analyzing pelvic MRI scans. Its flagship solution, EndomAI, is designed to help identify and map endometriosis lesions more effectively. The platform acts as a medical AI copilot rather than replacing physicians. Its purpose is to support specialists by improving consistency, speed, and accuracy during image interpretation.
One of the company’s biggest strengths is its access to large, high-quality datasets. According to the company, its models are trained using one of the world’s largest pelvic MRI datasets for endometriosis detection, built through collaborations with hospitals and medical experts across multiple regions.
The technology aims to address a major healthcare challenge. An endometriosis diagnosis can take many years because MRI interpretation is difficult and highly specialized. By helping radiologists identify patterns more consistently, Matricis.ai seeks to shorten this timeline and improve patient outcomes.
Growth and Company Development
Since its founding, Matricis.ai has achieved several important milestones.
The startup gained recognition through innovation programs and startup ecosystems in France. Elise was selected as one of the entrepreneurs highlighted by Station F, one of Europe’s most prominent startup campuses. This recognition helped raise awareness of the company’s mission and potential impact.
The company also advanced from research and development into clinical validation. Over time, its technology moved closer to real-world deployment in hospitals and imaging centers. By 2026, Matricis.ai had launched its first clinical pilot program in the United States with SimonMed, a major outpatient medical imaging network. This represented an important step in international expansion and demonstrated growing confidence in the technology.
Public information about major venture funding rounds remains limited. However, the company has benefited from institutional support, accelerator programs, research partnerships, and healthcare collaborations that have helped fuel its growth. Available records show a steady progression from academic research to commercial healthcare applications.
Leadership Style
Elise Mekkaoui’s leadership style reflects both analytical thinking and personal commitment.
People who have worked with her often describe her as determined, detail-oriented, and eager to learn. She is known for asking questions, studying complex subjects deeply, and building knowledge quickly when entering unfamiliar areas. These qualities have helped her bridge the worlds of healthcare, artificial intelligence, and entrepreneurship.
Her leadership approach is highly collaborative. From the beginning, she worked closely with radiologists, researchers, engineers, and healthcare institutions. Rather than trying to develop technology in isolation, she focused on co-creating solutions with the people who would ultimately use them. This collaborative mindset has become an important part of Matricis.ai’s culture.
Elise also demonstrates resilience. Building medical technology requires long development cycles, regulatory considerations, scientific validation, and extensive testing. She has repeatedly emphasized the importance of persistence and adaptability while moving the company forward.
Industry Expertise and Vision
Elise’s expertise sits at the intersection of artificial intelligence, healthcare innovation, data analysis, and entrepreneurship.
She understands that technology alone does not solve healthcare problems. Successful medical innovation requires collaboration between clinicians, researchers, regulators, and technology developers. This understanding has shaped Matricis.ai’s strategy from its earliest days.
Her broader vision extends beyond endometriosis. While the company’s initial focus remains on improving diagnosis for this disease, Elise has spoken about applying similar approaches to other women’s health conditions. She has expressed interest in areas such as polycystic ovary syndrome and the female-specific presentation of certain cardiovascular diseases, which remain under-researched and often underdiagnosed.
By combining AI with medical imaging, she hopes to create tools that help doctors make more informed decisions while reducing disparities in healthcare access.
Impact on Efficiency and Healthcare Projects
One of the most significant aspects of Elise’s work is its focus on efficiency.
Radiologists often face increasing workloads and growing demand for imaging services. AI-powered tools can help streamline parts of the diagnostic process by highlighting potential findings and supporting clinical decision-making. Matricis.ai’s technology is designed to save time while maintaining high standards of medical quality.
The company’s approach also helps distribute expertise more widely. Highly specialized radiologists are limited in number, especially in certain regions. By embedding expert knowledge into software systems, Matricis.ai aims to make advanced diagnostic support available to a larger number of healthcare providers.
For patients, this could mean faster diagnoses, quicker access to treatment, and fewer years spent searching for answers.
Achievements and Recognition
Although still early in her entrepreneurial journey, Elise Mekkaoui has already achieved notable recognition.
She helped build a company that emerged from leading French research institutions and entered the competitive health-tech sector. She earned recognition from Station F’s entrepreneurship programs and attracted partnerships with respected medical organizations. Her work has been featured in major publications and innovation discussions focused on women’s health and artificial intelligence.
Most importantly, she has contributed to the development of technology that addresses a real and widespread healthcare challenge affecting millions of women worldwide.
Personal Approach
Beyond business and technology, Elise brings a human perspective to her work.
Her personal experience with endometriosis gives her a strong connection to the patients she hopes to help. This connection influences many of her decisions and keeps the company’s mission grounded in real-world impact. She frequently speaks about advancing research and improving healthcare outcomes rather than simply building technology for its own sake.
Outside work, she has expressed an interest in culture and learning. She enjoys attending the opera and reading science fiction, activities that provide inspiration and balance amid the demands of entrepreneurship.
Future Outlook
The future appears promising for both Elise Mekkaoui and Matricis.ai.
As healthcare systems increasingly adopt artificial intelligence, demand for clinically validated medical imaging tools is expected to grow. Matricis.ai’s transition from research to international clinical pilots demonstrates that the company is moving steadily toward broader deployment. The launch of U.S. clinical programs represents an important milestone and could open doors to larger healthcare markets.
Looking ahead, Elise’s long-term ambition appears to extend beyond a single disease. Her vision is to build technologies that improve diagnosis across multiple women’s health conditions while supporting doctors with reliable AI tools. If successful, her work could help reshape how complex diseases are detected and managed.
From a personal health challenge to a growing international health-tech company, Elise Mekkaoui’s journey demonstrates how determination, scientific collaboration, and purposeful innovation can create meaningful change. Her story is not only about entrepreneurship; it is about using technology to solve problems that matter and improving the lives of patients who have waited too long for answers.
